PT2318375E - Imidazole carboxamidas - Google Patents
Imidazole carboxamidas Download PDFInfo
- Publication number
- PT2318375E PT2318375E PT09790351T PT09790351T PT2318375E PT 2318375 E PT2318375 E PT 2318375E PT 09790351 T PT09790351 T PT 09790351T PT 09790351 T PT09790351 T PT 09790351T PT 2318375 E PT2318375 E PT 2318375E
- Authority
- PT
- Portugal
- Prior art keywords
- methyl
- compound
- trifluoromethyl
- mmol
- pharmaceutically acceptable
- Prior art date
Links
- NMIZONYLXCOHEF-UHFFFAOYSA-N 1h-imidazole-2-carboxamide Chemical class NC(=O)C1=NC=CN1 NMIZONYLXCOHEF-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 166
- 150000003839 salts Chemical class 0.000 claims description 40
- 239000001257 hydrogen Substances 0.000 claims description 32
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 28
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 22
- 238000011282 treatment Methods 0.000 claims description 14
- 150000002431 hydrogen Chemical group 0.000 claims description 11
- 125000001153 fluoro group Chemical group F* 0.000 claims description 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 10
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 208000020401 Depressive disease Diseases 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- 125000001246 bromo group Chemical group Br* 0.000 claims description 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims description 2
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 6
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 2
- SKNNATYDYVUYGI-UHFFFAOYSA-N CC(C)C(C(C=CC(OCC1=CC=C(CN)C=C1)=C1C(F)(F)F)=C1O)=O.CN1C=NC(C(O)=O)=C1 Chemical compound CC(C)C(C(C=CC(OCC1=CC=C(CN)C=C1)=C1C(F)(F)F)=C1O)=O.CN1C=NC(C(O)=O)=C1 SKNNATYDYVUYGI-UHFFFAOYSA-N 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- QCGGXGCODUUTLZ-UHFFFAOYSA-N [Na].[Na].[Na].[Na] Chemical compound [Na].[Na].[Na].[Na] QCGGXGCODUUTLZ-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- RDOVSPPEPGMKEB-UHFFFAOYSA-L trisodium;sulfate Chemical compound [Na+].[Na+].[Na+].[O-]S([O-])(=O)=O RDOVSPPEPGMKEB-UHFFFAOYSA-L 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 164
- 238000001819 mass spectrum Methods 0.000 description 156
- -1 IMIDAZOLE CARBOXAMIDES Chemical class 0.000 description 84
- 238000002360 preparation method Methods 0.000 description 74
- 239000011541 reaction mixture Substances 0.000 description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 54
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 42
- 239000012074 organic phase Substances 0.000 description 42
- 239000000243 solution Substances 0.000 description 41
- 239000007787 solid Substances 0.000 description 38
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 35
- 239000012458 free base Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 33
- 238000005481 NMR spectroscopy Methods 0.000 description 29
- 239000012267 brine Substances 0.000 description 29
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 29
- 230000004044 response Effects 0.000 description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 239000000126 substance Substances 0.000 description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 26
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 26
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 25
- 229910052938 sodium sulfate Inorganic materials 0.000 description 25
- 235000011152 sodium sulphate Nutrition 0.000 description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 238000003756 stirring Methods 0.000 description 23
- 239000012141 concentrate Substances 0.000 description 22
- 239000000706 filtrate Substances 0.000 description 22
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 239000000741 silica gel Substances 0.000 description 19
- 229910002027 silica gel Inorganic materials 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- 239000008346 aqueous phase Substances 0.000 description 13
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 13
- 235000019341 magnesium sulphate Nutrition 0.000 description 13
- 102000005962 receptors Human genes 0.000 description 13
- 108020003175 receptors Proteins 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 238000007792 addition Methods 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 208000019901 Anxiety disease Diseases 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 10
- 229910052786 argon Inorganic materials 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000036506 anxiety Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 6
- 206010020843 Hyperthermia Diseases 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 230000036031 hyperthermia Effects 0.000 description 6
- 239000012280 lithium aluminium hydride Substances 0.000 description 6
- 230000002787 reinforcement Effects 0.000 description 6
- NYFNJYJWOHQAMU-UHFFFAOYSA-N 1-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=C(O)C(C(F)(F)F)=C1O NYFNJYJWOHQAMU-UHFFFAOYSA-N 0.000 description 5
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000003818 flash chromatography Methods 0.000 description 5
- 229930195712 glutamate Natural products 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 238000012002 interactive response technology Methods 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000001931 thermography Methods 0.000 description 5
- WZTRQGJMMHMFGH-UHFFFAOYSA-N 1-methyl-imidazole-4-carboxylic acid Chemical compound CN1C=NC(C(O)=O)=C1 WZTRQGJMMHMFGH-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- 208000011688 Generalised anxiety disease Diseases 0.000 description 4
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 description 4
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 239000012131 assay buffer Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 208000029364 generalized anxiety disease Diseases 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 4
- 229910052808 lithium carbonate Inorganic materials 0.000 description 4
- 208000024714 major depressive disease Diseases 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 4
- LCZVKKUAUWQDPX-UHFFFAOYSA-N tert-butyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]ethyl]amino]acetate Chemical compound CC(=O)OC1=CC=CC=C1CN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1=CC=CC=C1OC(C)=O LCZVKKUAUWQDPX-UHFFFAOYSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 3
- UIAJWNXLQAGBMA-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-2-methylpropan-1-one Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)C(C)C)=CC=C1OCC1=CC=CC=C1 UIAJWNXLQAGBMA-UHFFFAOYSA-N 0.000 description 3
- ZZHILWYVFMYBGD-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-2-methylpropan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC1=CC=C(CN)C=C1 ZZHILWYVFMYBGD-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 3
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- GNSCYCNQOANMTI-UHFFFAOYSA-N [6-(aminomethyl)pyridin-3-yl]methanol Chemical compound NCC1=CC=C(CO)C=N1 GNSCYCNQOANMTI-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229960002464 fluoxetine Drugs 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- NLSUCNKNEPJLAV-UHFFFAOYSA-N methyl 1-tritylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OC)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 NLSUCNKNEPJLAV-UHFFFAOYSA-N 0.000 description 3
- UAYKHVMBFFBZFI-UHFFFAOYSA-N methyl 6-(chloromethyl)pyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(CCl)N=C1 UAYKHVMBFFBZFI-UHFFFAOYSA-N 0.000 description 3
- QVLONHSXRWCCAE-UHFFFAOYSA-N methyl 6-(hydroxymethyl)pyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(CO)N=C1 QVLONHSXRWCCAE-UHFFFAOYSA-N 0.000 description 3
- AMCABIVMXHPLIT-UHFFFAOYSA-N n-[[4-(iodomethyl)phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound CN1C=NC(C(=O)NCC=2C=CC(CI)=CC=2)=C1 AMCABIVMXHPLIT-UHFFFAOYSA-N 0.000 description 3
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 2
- MWOGNXZJWMLRTF-UHFFFAOYSA-N 1-(2,4-dihydroxy-3-iodophenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=C(O)C(I)=C1O MWOGNXZJWMLRTF-UHFFFAOYSA-N 0.000 description 2
- RFLAUWNOBFBDSR-UHFFFAOYSA-N 1-(2,4-dihydroxy-3-iodophenyl)-3-methylbutan-1-one Chemical compound CC(C)CC(=O)C1=CC=C(O)C(I)=C1O RFLAUWNOBFBDSR-UHFFFAOYSA-N 0.000 description 2
- XMZKXYBXQCAUHQ-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=C(O)C=C1O XMZKXYBXQCAUHQ-UHFFFAOYSA-N 0.000 description 2
- AHJFALLJPKZLQJ-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-3,3-dimethylbutan-1-one Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)CC(C)(C)C)=CC=C1OCC1=CC=CC=C1 AHJFALLJPKZLQJ-UHFFFAOYSA-N 0.000 description 2
- HKUHTZJOIMPSGS-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-3-methylbutan-1-one Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)CC(C)C)=CC=C1OCC1=CC=CC=C1 HKUHTZJOIMPSGS-UHFFFAOYSA-N 0.000 description 2
- KQEAFARTNDONRS-UHFFFAOYSA-N 1-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]-3-methylbutan-1-one Chemical compound CC(C)CC(=O)C1=CC=C(O)C(C(F)(F)F)=C1O KQEAFARTNDONRS-UHFFFAOYSA-N 0.000 description 2
- OELDMNJBYZUFTD-UHFFFAOYSA-N 1-[2-hydroxy-4-[[3-methyl-4-(methylaminomethyl)phenyl]methoxy]-3-(trifluoromethyl)phenyl]-2-methylpropan-1-one;hydrochloride Chemical compound Cl.C1=C(C)C(CNC)=CC=C1COC1=CC=C(C(=O)C(C)C)C(O)=C1C(F)(F)F OELDMNJBYZUFTD-UHFFFAOYSA-N 0.000 description 2
- OXBPPKGLHMEEBU-UHFFFAOYSA-N 1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]-2-methylpropan-1-one Chemical compound IC1=C(OCC=2C=CC=CC=2)C(C(=O)C(C)C)=CC=C1OCC1=CC=CC=C1 OXBPPKGLHMEEBU-UHFFFAOYSA-N 0.000 description 2
- WGPOLGBWNIOCBX-UHFFFAOYSA-N 1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]-3-methylbutan-1-one Chemical compound IC1=C(OCC=2C=CC=CC=2)C(C(=O)CC(C)C)=CC=C1OCC1=CC=CC=C1 WGPOLGBWNIOCBX-UHFFFAOYSA-N 0.000 description 2
- GEFZSFHAPNRRGA-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-3,3-dimethylbutan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)CC(C)(C)C)=CC=C1OCC1=CC=C(CN)C=C1 GEFZSFHAPNRRGA-UHFFFAOYSA-N 0.000 description 2
- TYBNOOXZPUQUCI-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-3-methylbutan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)CC(C)C)=CC=C1OCC1=CC=C(CN)C=C1 TYBNOOXZPUQUCI-UHFFFAOYSA-N 0.000 description 2
- UQQHMXJCLHSYRV-UHFFFAOYSA-N 1-tritylimidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 UQQHMXJCLHSYRV-UHFFFAOYSA-N 0.000 description 2
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical compound OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 description 2
- KYWMCFOWDYFYLV-UHFFFAOYSA-N 1h-imidazole-2-carboxylic acid Chemical compound OC(=O)C1=NC=CN1 KYWMCFOWDYFYLV-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- YZOGROCAAWYRBU-UHFFFAOYSA-N 2-cyclopropyl-n-methoxy-n-methylacetamide Chemical compound CON(C)C(=O)CC1CC1 YZOGROCAAWYRBU-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 101000887162 Gallus gallus Gallinacin-5 Proteins 0.000 description 2
- 101000887166 Gallus gallus Gallinacin-7 Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 101000608768 Rattus norvegicus Galectin-5 Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- SLYJNCGSRIKURD-UHFFFAOYSA-N [2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-cyclopropylmethanone Chemical compound C1=CC(C(=O)C2CC2)=C(OCC=2C=CC=CC=2)C(C(F)(F)F)=C1OCC1=CC=CC=C1 SLYJNCGSRIKURD-UHFFFAOYSA-N 0.000 description 2
- LEVARBQDITXONO-UHFFFAOYSA-N [2-bromo-5-[tert-butyl(dimethyl)silyl]oxyphenoxy]-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=C(Br)C(O[Si](C)(C)C(C)(C)C)=C1 LEVARBQDITXONO-UHFFFAOYSA-N 0.000 description 2
- GUEAGPLRVIOLMX-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanol;hydrochloride Chemical compound Cl.NCC1=CC=C(CO)C=C1 GUEAGPLRVIOLMX-UHFFFAOYSA-N 0.000 description 2
- 102000030621 adenylate cyclase Human genes 0.000 description 2
- 108060000200 adenylate cyclase Proteins 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- CYPCWFKNFJRMQN-UHFFFAOYSA-N ethyl 1-methylimidazole-4-carboxylate Chemical compound CCOC(=O)C1=CN(C)C=N1 CYPCWFKNFJRMQN-UHFFFAOYSA-N 0.000 description 2
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000003257 excitatory amino acid Substances 0.000 description 2
- 230000002461 excitatory amino acid Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002977 hyperthermial effect Effects 0.000 description 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 2
- 229960004801 imipramine Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 102000006239 metabotropic receptors Human genes 0.000 description 2
- 108020004083 metabotropic receptors Proteins 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- FPISVJZHEXEKFZ-UHFFFAOYSA-N methyl 1-propan-2-ylimidazole-4-carboxylate Chemical compound COC(=O)C1=CN(C(C)C)C=N1 FPISVJZHEXEKFZ-UHFFFAOYSA-N 0.000 description 2
- GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 description 2
- YBEKNOSAAIRRRW-UHFFFAOYSA-N methyl 3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]benzoate Chemical compound COC(=O)C1=CC=CC(CNC(=O)OC(C)(C)C)=C1 YBEKNOSAAIRRRW-UHFFFAOYSA-N 0.000 description 2
- DFFXODHIBKZVSS-UHFFFAOYSA-N methyl 3-[[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]methyl]benzoate Chemical compound COC(=O)C1=CC=CC(CN(C)C(=O)OC(C)(C)C)=C1 DFFXODHIBKZVSS-UHFFFAOYSA-N 0.000 description 2
- IEPLSLWGRRQIPX-UHFFFAOYSA-N methyl 4-(aminomethyl)-2-chlorobenzoate Chemical compound COC(=O)C1=CC=C(CN)C=C1Cl IEPLSLWGRRQIPX-UHFFFAOYSA-N 0.000 description 2
- VHNOQKYAYSLOAR-UHFFFAOYSA-N methyl 4-(azidomethyl)-2-chlorobenzoate Chemical compound COC(=O)C1=CC=C(CN=[N+]=[N-])C=C1Cl VHNOQKYAYSLOAR-UHFFFAOYSA-N 0.000 description 2
- LGEMXFQDNNYNGQ-UHFFFAOYSA-N methyl 4-(bromomethyl)-2-chlorobenzoate Chemical compound COC(=O)C1=CC=C(CBr)C=C1Cl LGEMXFQDNNYNGQ-UHFFFAOYSA-N 0.000 description 2
- BTSFXVSAECXZNJ-UHFFFAOYSA-N methyl 4-cyano-2-fluorobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C=C1F BTSFXVSAECXZNJ-UHFFFAOYSA-N 0.000 description 2
- UDAQXROOFWMMQD-UHFFFAOYSA-N methyl 6-(azidomethyl)pyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(CN=[N+]=[N-])N=C1 UDAQXROOFWMMQD-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- NRBNGHCYDWUVLC-UHFFFAOYSA-N mtep Chemical compound S1C(C)=NC(C#CC=2C=NC=CC=2)=C1 NRBNGHCYDWUVLC-UHFFFAOYSA-N 0.000 description 2
- ILGZQIYQGIRFRG-UHFFFAOYSA-N n-[[4-(hydroxymethyl)phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound CN1C=NC(C(=O)NCC=2C=CC(CO)=CC=2)=C1 ILGZQIYQGIRFRG-UHFFFAOYSA-N 0.000 description 2
- XITQUSLLOSKDTB-UHFFFAOYSA-N nitrofen Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(Cl)C=C1Cl XITQUSLLOSKDTB-UHFFFAOYSA-N 0.000 description 2
- 229960002296 paroxetine Drugs 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 2
- 239000001230 potassium iodate Substances 0.000 description 2
- 235000006666 potassium iodate Nutrition 0.000 description 2
- 229940093930 potassium iodate Drugs 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- KUEPOWVQABAWRK-UHFFFAOYSA-N tert-butyl n-[[4-(hydroxymethyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(CO)C=C1 KUEPOWVQABAWRK-UHFFFAOYSA-N 0.000 description 2
- QLDOZKYWZFXDLT-UHFFFAOYSA-N tert-butyl n-[[4-[[3-hydroxy-4-(2-methylpropanoyl)-2-(trifluoromethyl)phenoxy]methyl]-2-methylphenyl]methyl]carbamate Chemical compound FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC1=CC=C(CNC(=O)OC(C)(C)C)C(C)=C1 QLDOZKYWZFXDLT-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- MXIGALIASISPNU-UHFFFAOYSA-N (3-chloro-4-methylphenyl)methanamine Chemical compound CC1=CC=C(CN)C=C1Cl MXIGALIASISPNU-UHFFFAOYSA-N 0.000 description 1
- YKELQOVHBBARAK-UHFFFAOYSA-N (3-chloro-4-methylphenyl)methylcarbamic acid Chemical compound ClC=1C=C(CNC(O)=O)C=CC=1C YKELQOVHBBARAK-UHFFFAOYSA-N 0.000 description 1
- UOWRPTFJISFGPI-UHFFFAOYSA-N (3-methoxycarbonylphenyl)methylazanium;chloride Chemical compound Cl.COC(=O)C1=CC=CC(CN)=C1 UOWRPTFJISFGPI-UHFFFAOYSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- IWADIQGGJLCBRK-UHFFFAOYSA-N 1-(2,4-Dihydroxyphenyl)-1-butanone Chemical compound CCCC(=O)C1=CC=C(O)C=C1O IWADIQGGJLCBRK-UHFFFAOYSA-N 0.000 description 1
- KOSOATVCRIABII-UHFFFAOYSA-N 1-(2,4-dihydroxy-3-iodophenyl)butan-1-one Chemical compound CCCC(=O)c1ccc(O)c(I)c1O KOSOATVCRIABII-UHFFFAOYSA-N 0.000 description 1
- JHTYTCIQMRHXMP-UHFFFAOYSA-N 1-(2,4-dihydroxy-3-iodophenyl)ethanone Chemical compound CC(=O)C1=CC=C(O)C(I)=C1O JHTYTCIQMRHXMP-UHFFFAOYSA-N 0.000 description 1
- AFLATBREDGLLKS-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-3-methylbutan-1-one Chemical compound CC(C)CC(=O)C1=CC=C(O)C=C1O AFLATBREDGLLKS-UHFFFAOYSA-N 0.000 description 1
- NLSYFKRCWFNXLL-UHFFFAOYSA-N 1-(3-bromo-2,4-dihydroxyphenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=C(O)C(Br)=C1O NLSYFKRCWFNXLL-UHFFFAOYSA-N 0.000 description 1
- UHKACIHWWGAFGA-UHFFFAOYSA-N 1-(3-bromo-2,4-dihydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC=C(O)C(Br)=C1O UHKACIHWWGAFGA-UHFFFAOYSA-N 0.000 description 1
- SLASFYGUIRAANR-UHFFFAOYSA-N 1-(3-bromo-2-hydroxy-4-methoxyphenyl)ethanone Chemical compound COC1=CC=C(C(C)=O)C(O)=C1Br SLASFYGUIRAANR-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- YSMXLKXISZOVAW-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-2-cyclopentylethanone Chemical compound C1=CC(C(=O)CC2CCCC2)=C(OCC=2C=CC=CC=2)C(C(F)(F)F)=C1OCC1=CC=CC=C1 YSMXLKXISZOVAW-UHFFFAOYSA-N 0.000 description 1
- TZTKEUDMPDGBRH-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]butan-1-one Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)CCC)=CC=C1OCC1=CC=CC=C1 TZTKEUDMPDGBRH-UHFFFAOYSA-N 0.000 description 1
- KQQPPDCWBMEDGH-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)C)=CC=C1OCC1=CC=CC=C1 KQQPPDCWBMEDGH-UHFFFAOYSA-N 0.000 description 1
- HBSVHMYNWUZWDM-UHFFFAOYSA-N 1-[2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]propan-1-one Chemical compound FC(F)(F)C1=C(OCC=2C=CC=CC=2)C(C(=O)CC)=CC=C1OCC1=CC=CC=C1 HBSVHMYNWUZWDM-UHFFFAOYSA-N 0.000 description 1
- OQOCESUAFDVVBQ-UHFFFAOYSA-N 1-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(O)C(C(F)(F)F)=C1O OQOCESUAFDVVBQ-UHFFFAOYSA-N 0.000 description 1
- JEDZWRQFMKIBIN-UHFFFAOYSA-N 1-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]propan-1-one Chemical compound CCC(=O)C1=CC=C(O)C(C(F)(F)F)=C1O JEDZWRQFMKIBIN-UHFFFAOYSA-N 0.000 description 1
- VXXJMZIYWLMWAM-UHFFFAOYSA-N 1-[2-hydroxy-4-[[3-(methylaminomethyl)phenyl]methoxy]-3-(trifluoromethyl)phenyl]ethanone;hydrochloride Chemical compound Cl.CNCC1=CC=CC(COC=2C(=C(O)C(C(C)=O)=CC=2)C(F)(F)F)=C1 VXXJMZIYWLMWAM-UHFFFAOYSA-N 0.000 description 1
- NQEURYXMPILLSB-UHFFFAOYSA-N 1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]butan-1-one Chemical compound IC1=C(OCC=2C=CC=CC=2)C(C(=O)CCC)=CC=C1OCC1=CC=CC=C1 NQEURYXMPILLSB-UHFFFAOYSA-N 0.000 description 1
- PCZFROLOTAORMT-UHFFFAOYSA-N 1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]ethanone Chemical compound IC1=C(OCC=2C=CC=CC=2)C(C(=O)C)=CC=C1OCC1=CC=CC=C1 PCZFROLOTAORMT-UHFFFAOYSA-N 0.000 description 1
- QNXOULXXNFFXMT-UHFFFAOYSA-N 1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]propan-1-one Chemical compound IC1=C(OCC=2C=CC=CC=2)C(C(=O)CC)=CC=C1OCC1=CC=CC=C1 QNXOULXXNFFXMT-UHFFFAOYSA-N 0.000 description 1
- NMBSYBXFRXBYAL-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)-2-chlorophenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-2-methylpropan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC1=CC=C(CN)C=C1Cl NMBSYBXFRXBYAL-UHFFFAOYSA-N 0.000 description 1
- DEUGMHUHQSFDFK-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)-2-chlorophenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-3,3-dimethylbutan-1-one Chemical compound FC(F)(F)C1=C(O)C(C(=O)CC(C)(C)C)=CC=C1OCC1=CC=C(CN)C=C1Cl DEUGMHUHQSFDFK-UHFFFAOYSA-N 0.000 description 1
- DRGBJBSQMWTEGS-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)-2-chlorophenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-3,3-dimethylbutan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)CC(C)(C)C)=CC=C1OCC1=CC=C(CN)C=C1Cl DRGBJBSQMWTEGS-UHFFFAOYSA-N 0.000 description 1
- WPXALJBILMVJBK-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-2-cyclopentylethanone;hydrochloride Chemical compound Cl.C1=CC(CN)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)CC1CCCC1 WPXALJBILMVJBK-UHFFFAOYSA-N 0.000 description 1
- YXVSZFPDHMVKJG-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-2-cyclopropylethanone 1-methylimidazole-4-carboxylic acid Chemical compound CN1C=NC(C(O)=O)=C1.NCC1=CC=C(COC(C=C2)=C(C(F)(F)F)C(O)=C2C(CC2CC2)=O)C=C1 YXVSZFPDHMVKJG-UHFFFAOYSA-N 0.000 description 1
- GPKWPIIWHPTIFF-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-2-cyclopropylethanone;hydrochloride Chemical compound Cl.C1=CC(CN)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)CC1CC1 GPKWPIIWHPTIFF-UHFFFAOYSA-N 0.000 description 1
- CBEVFCPKBKHDIX-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]butan-1-one;hydrochloride Chemical compound Cl.FC(F)(F)C1=C(O)C(C(=O)CCC)=CC=C1OCC1=CC=C(CN)C=C1 CBEVFCPKBKHDIX-UHFFFAOYSA-N 0.000 description 1
- ZISKNXYDIIIAIJ-UHFFFAOYSA-N 1-[4-[[4-(aminomethyl)phenyl]methoxy]-3-bromo-2-hydroxyphenyl]-3-methylbutan-1-one hydrochloride Chemical compound CC(C)CC(=O)C1=C(C(=C(C=C1)OCC2=CC=C(C=C2)CN)Br)O.Cl ZISKNXYDIIIAIJ-UHFFFAOYSA-N 0.000 description 1
- BLRHMMGNCXNXJL-UHFFFAOYSA-N 1-methylindole Chemical compound C1=CC=C2N(C)C=CC2=C1 BLRHMMGNCXNXJL-UHFFFAOYSA-N 0.000 description 1
- XFCGFENUIALWFJ-UHFFFAOYSA-N 1-propan-2-ylimidazole-4-carboxylic acid Chemical compound CC(C)N1C=NC(C(O)=O)=C1 XFCGFENUIALWFJ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- NEUYKPFEHZYUEQ-UHFFFAOYSA-N 2-chloro-4-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]benzoic acid Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(C(O)=O)C(Cl)=C1 NEUYKPFEHZYUEQ-UHFFFAOYSA-N 0.000 description 1
- MYJUBDJLKREUGU-UHFFFAOYSA-N 2-chloro-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(Cl)=C1 MYJUBDJLKREUGU-UHFFFAOYSA-N 0.000 description 1
- KGDPWXPQAZIYOB-UHFFFAOYSA-N 2-cyclobutyl-1-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]ethanone Chemical compound OC1=C(C(F)(F)F)C(O)=CC=C1C(=O)CC1CCC1 KGDPWXPQAZIYOB-UHFFFAOYSA-N 0.000 description 1
- CEUXIAUEIGSQSZ-UHFFFAOYSA-N 2-cyclopentylacetaldehyde Chemical compound O=CCC1CCCC1 CEUXIAUEIGSQSZ-UHFFFAOYSA-N 0.000 description 1
- HZROUTBBVRHQRE-UHFFFAOYSA-N 2-cyclopropyl-1-(2,4-dihydroxy-3-iodophenyl)ethanone Chemical compound OC1=C(I)C(O)=CC=C1C(=O)CC1CC1 HZROUTBBVRHQRE-UHFFFAOYSA-N 0.000 description 1
- FUGZWKPBAIKAQB-UHFFFAOYSA-N 2-cyclopropyl-1-(2,4-dihydroxyphenyl)ethanone Chemical compound OC1=CC(O)=CC=C1C(=O)CC1CC1 FUGZWKPBAIKAQB-UHFFFAOYSA-N 0.000 description 1
- VRWRTZONTKCEHR-UHFFFAOYSA-N 2-cyclopropyl-1-[3-iodo-2,4-bis(phenylmethoxy)phenyl]ethanone Chemical compound C1=CC(C(=O)CC2CC2)=C(OCC=2C=CC=CC=2)C(I)=C1OCC1=CC=CC=C1 VRWRTZONTKCEHR-UHFFFAOYSA-N 0.000 description 1
- KVVDRQDTODKIJD-UHFFFAOYSA-N 2-cyclopropylacetic acid Chemical compound OC(=O)CC1CC1 KVVDRQDTODKIJD-UHFFFAOYSA-N 0.000 description 1
- SOWDWUPMHVDZGL-UHFFFAOYSA-N 2-methoxy-4-methylbenzoic acid Chemical compound COC1=CC(C)=CC=C1C(O)=O SOWDWUPMHVDZGL-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- ZMXZIBBECHOIJE-UHFFFAOYSA-N 3-methyl-2H-imidazole-1-carboxylic acid Chemical compound CN1CN(C=C1)C(O)=O ZMXZIBBECHOIJE-UHFFFAOYSA-N 0.000 description 1
- LPEBMDFRIKYFCF-UHFFFAOYSA-N 4-bromo-2-methylbenzonitrile Chemical compound CC1=CC(Br)=CC=C1C#N LPEBMDFRIKYFCF-UHFFFAOYSA-N 0.000 description 1
- KEJMSTJTAWACNI-UHFFFAOYSA-N 4-cyano-2-fluorobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1F KEJMSTJTAWACNI-UHFFFAOYSA-N 0.000 description 1
- ZWKNDLMYSLLMRF-UHFFFAOYSA-N 4-cyano-3-fluorobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C(F)=C1 ZWKNDLMYSLLMRF-UHFFFAOYSA-N 0.000 description 1
- ADCUEPOHPCPMCE-UHFFFAOYSA-N 4-cyanobenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1 ADCUEPOHPCPMCE-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 102000006941 Amino Acid Transport System X-AG Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- MYYBUFYPTMBPLG-UHFFFAOYSA-N CC1(CN=CN1)C(=O)O Chemical compound CC1(CN=CN1)C(=O)O MYYBUFYPTMBPLG-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- XJJKSDTVJXUOMP-UHFFFAOYSA-N ClC=1C=C(CNC(O)=O)C=CC1CO Chemical compound ClC=1C=C(CNC(O)=O)C=CC1CO XJJKSDTVJXUOMP-UHFFFAOYSA-N 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- 108091006151 Glutamate transporters Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 description 1
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- YUEFDCMVQXMXLG-UHFFFAOYSA-N [2,4-bis(phenylmethoxy)-3-(trifluoromethyl)phenyl]-cyclobutylmethanone Chemical compound C1=CC(C(=O)C2CCC2)=C(OCC=2C=CC=CC=2)C(C(F)(F)F)=C1OCC1=CC=CC=C1 YUEFDCMVQXMXLG-UHFFFAOYSA-N 0.000 description 1
- AVJXXLFGADEXEJ-UHFFFAOYSA-N [4-(aminomethyl)-3-fluorophenyl]methanol Chemical compound NCC1=CC=C(CO)C=C1F AVJXXLFGADEXEJ-UHFFFAOYSA-N 0.000 description 1
- BYDKRQULQOITTA-UHFFFAOYSA-N [4-[[3-hydroxy-4-(3-methylbutanoyl)-2-(trifluoromethyl)phenoxy]methyl]phenyl]methylcarbamic acid Chemical compound OC=1C(=C(OCC2=CC=C(CNC(O)=O)C=C2)C=CC1C(CC(C)C)=O)C(F)(F)F BYDKRQULQOITTA-UHFFFAOYSA-N 0.000 description 1
- QRVHRKGVGYAURG-UHFFFAOYSA-N [4-[[4-(aminomethyl)phenyl]methoxy]-2-hydroxy-3-(trifluoromethyl)phenyl]-cyclobutylmethanone;hydrochloride Chemical compound Cl.C1=CC(CN)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)C1CCC1 QRVHRKGVGYAURG-UHFFFAOYSA-N 0.000 description 1
- PTPUOMXKXCCSEN-UHFFFAOYSA-N acetyloxymethyl 2-[2-[2-[5-[3-(acetyloxymethoxy)-2,7-dichloro-6-oxoxanthen-9-yl]-2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]phenoxy]ethoxy]-n-[2-(acetyloxymethoxy)-2-oxoethyl]-4-methylanilino]acetate Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=C(C)C=C1OCCOC1=CC(C2=C3C=C(Cl)C(=O)C=C3OC3=CC(OCOC(C)=O)=C(Cl)C=C32)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O PTPUOMXKXCCSEN-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- GMBHLHMRHUMBHU-UHFFFAOYSA-N butan-2-one;hydrochloride Chemical compound Cl.CCC(C)=O GMBHLHMRHUMBHU-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- VIASBBRATCGVKJ-UHFFFAOYSA-N cyclobutyl-(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1CCC1 VIASBBRATCGVKJ-UHFFFAOYSA-N 0.000 description 1
- CKIQYFBSBWCACB-UHFFFAOYSA-N cyclobutyl-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]methanone Chemical compound OC1=C(C(F)(F)F)C(O)=CC=C1C(=O)C1CCC1 CKIQYFBSBWCACB-UHFFFAOYSA-N 0.000 description 1
- DCENVDJBXFOGOI-UHFFFAOYSA-N cyclobutyl-[3-iodo-2,4-bis(phenylmethoxy)phenyl]methanone Chemical compound C1=CC(C(=O)C2CCC2)=C(OCC=2C=CC=CC=2)C(I)=C1OCC1=CC=CC=C1 DCENVDJBXFOGOI-UHFFFAOYSA-N 0.000 description 1
- GPVQBRRZDNFGDE-UHFFFAOYSA-N cyclopentyl-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]methanone Chemical compound OC1=C(C(F)(F)F)C(O)=CC=C1C(=O)C1CCCC1 GPVQBRRZDNFGDE-UHFFFAOYSA-N 0.000 description 1
- WUPSPTVWIDQBBQ-UHFFFAOYSA-N cyclopentyl-[3-iodo-2,4-bis(phenylmethoxy)phenyl]methanone Chemical compound C1=CC(C(=O)C2CCCC2)=C(OCC=2C=CC=CC=2)C(I)=C1OCC1=CC=CC=C1 WUPSPTVWIDQBBQ-UHFFFAOYSA-N 0.000 description 1
- HFFJQBGUCYMTFY-UHFFFAOYSA-N cyclopropyl-(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1CC1 HFFJQBGUCYMTFY-UHFFFAOYSA-N 0.000 description 1
- LOZVMRUGOSWPAX-UHFFFAOYSA-N cyclopropyl-[2,4-dihydroxy-3-(trifluoromethyl)phenyl]methanone Chemical compound OC1=C(C(F)(F)F)C(O)=CC=C1C(=O)C1CC1 LOZVMRUGOSWPAX-UHFFFAOYSA-N 0.000 description 1
- MRYVBWGMJUKNSH-UHFFFAOYSA-N cyclopropyl-[3-iodo-2,4-bis(phenylmethoxy)phenyl]methanone Chemical compound C1=CC(C(=O)C2CC2)=C(OCC=2C=CC=CC=2)C(I)=C1OCC1=CC=CC=C1 MRYVBWGMJUKNSH-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- TUGSJNQAIMFEDY-UHFFFAOYSA-N dimethyl pyridine-2,5-dicarboxylate Chemical compound COC(=O)C1=CC=C(C(=O)OC)N=C1 TUGSJNQAIMFEDY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000928 excitatory amino acid agonist Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 230000001057 ionotropic effect Effects 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108010038445 metabotropic glutamate receptor 3 Proteins 0.000 description 1
- 108010038422 metabotropic glutamate receptor 4 Proteins 0.000 description 1
- KZPZTVKOJSKVBV-UHFFFAOYSA-N methyl 1-methylimidazole-4-carboxylate Chemical compound COC(=O)C1=CN(C)C=N1 KZPZTVKOJSKVBV-UHFFFAOYSA-N 0.000 description 1
- DVLGIQNHKLWSRU-UHFFFAOYSA-N methyl 1h-imidazole-5-carboxylate Chemical compound COC(=O)C1=CN=CN1 DVLGIQNHKLWSRU-UHFFFAOYSA-N 0.000 description 1
- AVNQOBATVQLYET-UHFFFAOYSA-N methyl 2-chloro-4-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]benzoate Chemical compound COC(=O)C1=CC=C(CNC(=O)OC(C)(C)C)C=C1Cl AVNQOBATVQLYET-UHFFFAOYSA-N 0.000 description 1
- PJZFAIKANVMKKU-UHFFFAOYSA-N methyl 2-chloro-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C=C1Cl PJZFAIKANVMKKU-UHFFFAOYSA-N 0.000 description 1
- KTFQDZCNPGFKAH-UHFFFAOYSA-N methyl 3-chloro-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(Cl)=C1 KTFQDZCNPGFKAH-UHFFFAOYSA-N 0.000 description 1
- WAGSGHIIJKPOHK-UHFFFAOYSA-N methyl 3-methyl-4-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]benzoate Chemical compound COC(=O)C1=CC=C(CNC(=O)OC(C)(C)C)C(C)=C1 WAGSGHIIJKPOHK-UHFFFAOYSA-N 0.000 description 1
- LCAZFABQXUTCSK-UHFFFAOYSA-N methyl 3-methyl-4-[[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]methyl]benzoate Chemical compound COC(=O)C1=CC=C(CN(C)C(=O)OC(C)(C)C)C(C)=C1 LCAZFABQXUTCSK-UHFFFAOYSA-N 0.000 description 1
- XPIUJBSUFHGVHI-UHFFFAOYSA-N methyl 4-(aminomethyl)-2,3-difluorobenzoate Chemical compound COC(=O)C1=CC=C(CN)C(F)=C1F XPIUJBSUFHGVHI-UHFFFAOYSA-N 0.000 description 1
- GGAFQXNKBHDZLI-UHFFFAOYSA-N methyl 4-(aminomethyl)-2-fluorobenzoate Chemical compound COC(=O)C1=CC=C(CN)C=C1F GGAFQXNKBHDZLI-UHFFFAOYSA-N 0.000 description 1
- GNBQLMBPFKIXJX-UHFFFAOYSA-N methyl 4-(aminomethyl)-2-methoxybenzoate Chemical compound COC(=O)C1=CC=C(CN)C=C1OC GNBQLMBPFKIXJX-UHFFFAOYSA-N 0.000 description 1
- VXLLMVXXEXMLNL-UHFFFAOYSA-N methyl 4-(aminomethyl)-3-chlorobenzoate Chemical compound COC(=O)C1=CC=C(CN)C(Cl)=C1 VXLLMVXXEXMLNL-UHFFFAOYSA-N 0.000 description 1
- NNOBUPILNNMONK-UHFFFAOYSA-N methyl 4-(aminomethyl)-3-methoxybenzoate Chemical compound COC(=O)C1=CC=C(CN)C(OC)=C1 NNOBUPILNNMONK-UHFFFAOYSA-N 0.000 description 1
- CYGJEWIECWOXNH-UHFFFAOYSA-N methyl 4-(aminomethyl)-3-methylbenzoate Chemical compound COC(=O)C1=CC=C(CN)C(C)=C1 CYGJEWIECWOXNH-UHFFFAOYSA-N 0.000 description 1
- TXWZNEPFUMOXPP-UHFFFAOYSA-N methyl 4-(azidomethyl)-3-methoxybenzoate Chemical compound COC(=O)C1=CC=C(CN=[N+]=[N-])C(OC)=C1 TXWZNEPFUMOXPP-UHFFFAOYSA-N 0.000 description 1
- DKTXXBLWUUYFNL-UHFFFAOYSA-N methyl 4-(bromomethyl)-2,3-difluorobenzoate Chemical compound COC(=O)C1=CC=C(CBr)C(F)=C1F DKTXXBLWUUYFNL-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- HDIWYFOUSUGFLF-UHFFFAOYSA-N n-[[2,3-difluoro-4-[[3-hydroxy-4-(2-methylpropanoyl)-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC(C(=C1F)F)=CC=C1CNC(=O)C1=CN(C)C=N1 HDIWYFOUSUGFLF-UHFFFAOYSA-N 0.000 description 1
- FGYPRXRXTADDTR-UHFFFAOYSA-N n-[[2-chloro-4-[[3-hydroxy-4-(2-methylpropanoyl)-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC(C=C1Cl)=CC=C1CNC(=O)C1=CN(C)C=N1 FGYPRXRXTADDTR-UHFFFAOYSA-N 0.000 description 1
- QMRIRVBALXSKSE-UHFFFAOYSA-N n-[[3-[[4-acetyl-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-n,3-dimethylimidazole-4-carboxamide Chemical compound C=1N=CN(C)C=1C(=O)N(C)CC(C=1)=CC=CC=1COC1=CC=C(C(C)=O)C(O)=C1C(F)(F)F QMRIRVBALXSKSE-UHFFFAOYSA-N 0.000 description 1
- JSUSNSGLGCUPBD-UHFFFAOYSA-N n-[[3-chloro-4-[[4-(3,3-dimethylbutanoyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide;hydrochloride Chemical compound Cl.CN1C=NC(C(=O)NCC=2C=C(Cl)C(COC=3C(=C(O)C(C(=O)CC(C)(C)C)=CC=3)C(F)(F)F)=CC=2)=C1 JSUSNSGLGCUPBD-UHFFFAOYSA-N 0.000 description 1
- RYINQFMHVVYWNS-UHFFFAOYSA-N n-[[4-[[3-hydroxy-4-(2-methylpropanoyl)-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)C(C)C)=CC=C1OCC(C=C1)=CC=C1CNC(=O)C1=CN(C)C=N1 RYINQFMHVVYWNS-UHFFFAOYSA-N 0.000 description 1
- DEFLVZJSOBVKHH-UHFFFAOYSA-N n-[[4-[[3-hydroxy-4-(3-methylbutanoyl)-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)CC(C)C)=CC=C1OCC(C=C1)=CC=C1CNC(=O)C1=CN(C)C=N1 DEFLVZJSOBVKHH-UHFFFAOYSA-N 0.000 description 1
- XBVCVMMSZPIEDX-UHFFFAOYSA-N n-[[4-[[4-(3,3-dimethylbutanoyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-tritylimidazole-4-carboxamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)CC(C)(C)C)=CC=C1OCC(C=C1)=CC=C1CNC(=O)C1=CN(C(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)C=N1 XBVCVMMSZPIEDX-UHFFFAOYSA-N 0.000 description 1
- RXQVWKQZLMUTAZ-UHFFFAOYSA-N n-[[4-[[4-(cyclobutanecarbonyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound CN1C=NC(C(=O)NCC=2C=CC(COC=3C(=C(O)C(C(=O)C4CCC4)=CC=3)C(F)(F)F)=CC=2)=C1 RXQVWKQZLMUTAZ-UHFFFAOYSA-N 0.000 description 1
- MKYANLSHZXGNJT-UHFFFAOYSA-N n-[[4-[[4-(cyclopentanecarbonyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]-1-methylimidazole-4-carboxamide Chemical compound CN1C=NC(C(=O)NCC=2C=CC(COC=3C(=C(O)C(C(=O)C4CCCC4)=CC=3)C(F)(F)F)=CC=2)=C1 MKYANLSHZXGNJT-UHFFFAOYSA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 description 1
- 229960003770 reboxetine Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 1
- BOCWGBMVJKSUOD-UHFFFAOYSA-N tert-butyl 1h-imidazole-5-carboxylate Chemical compound CC(C)(C)OC(=O)C1=CN=CN1 BOCWGBMVJKSUOD-UHFFFAOYSA-N 0.000 description 1
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- NFHDHPLNCCIKPF-UHFFFAOYSA-N tert-butyl n-[[3-(hydroxymethyl)phenyl]methyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CC1=CC=CC(CO)=C1 NFHDHPLNCCIKPF-UHFFFAOYSA-N 0.000 description 1
- QNDFFICIIGQGDV-UHFFFAOYSA-N tert-butyl n-[[3-(hydroxymethyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(CO)=C1 QNDFFICIIGQGDV-UHFFFAOYSA-N 0.000 description 1
- JFXAHPWMRAOYGV-UHFFFAOYSA-N tert-butyl n-[[3-(iodomethyl)phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(CI)=C1 JFXAHPWMRAOYGV-UHFFFAOYSA-N 0.000 description 1
- BIHMLEFRUOZAOB-UHFFFAOYSA-N tert-butyl n-[[3-[[4-acetyl-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]carbamate Chemical compound FC(F)(F)C1=C(O)C(C(=O)C)=CC=C1OCC1=CC=CC(CNC(=O)OC(C)(C)C)=C1 BIHMLEFRUOZAOB-UHFFFAOYSA-N 0.000 description 1
- PDMDQEVZJFWYLS-UHFFFAOYSA-N tert-butyl n-[[4-[[4-(2-cyclopropylacetyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)CC1CC1 PDMDQEVZJFWYLS-UHFFFAOYSA-N 0.000 description 1
- ODSPNWKLTCAOTM-UHFFFAOYSA-N tert-butyl n-[[4-[[4-(cyclobutanecarbonyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)C1CCC1 ODSPNWKLTCAOTM-UHFFFAOYSA-N 0.000 description 1
- KIOHVWNAAOEGRB-UHFFFAOYSA-N tert-butyl n-[[4-[[4-(cyclopentanecarbonyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)C1CCCC1 KIOHVWNAAOEGRB-UHFFFAOYSA-N 0.000 description 1
- VGIDHHRUTLKSPP-UHFFFAOYSA-N tert-butyl n-[[4-[[4-(cyclopropanecarbonyl)-3-hydroxy-2-(trifluoromethyl)phenoxy]methyl]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1COC(C(=C1O)C(F)(F)F)=CC=C1C(=O)C1CC1 VGIDHHRUTLKSPP-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8177408P | 2008-07-18 | 2008-07-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2318375E true PT2318375E (pt) | 2012-10-22 |
Family
ID=41128155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT09790351T PT2318375E (pt) | 2008-07-18 | 2009-07-14 | Imidazole carboxamidas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7754742B2 (enExample) |
| EP (1) | EP2318375B1 (enExample) |
| JP (1) | JP5379227B2 (enExample) |
| KR (1) | KR101287713B1 (enExample) |
| CN (1) | CN102099344B (enExample) |
| AR (1) | AR074631A1 (enExample) |
| BR (1) | BRPI0915977A2 (enExample) |
| CA (1) | CA2731215C (enExample) |
| CY (1) | CY1113315T1 (enExample) |
| DK (1) | DK2318375T3 (enExample) |
| EA (1) | EA018434B1 (enExample) |
| ES (1) | ES2393243T3 (enExample) |
| HR (1) | HRP20120830T1 (enExample) |
| MX (1) | MX2011000611A (enExample) |
| PL (1) | PL2318375T3 (enExample) |
| PT (1) | PT2318375E (enExample) |
| SI (1) | SI2318375T1 (enExample) |
| TW (1) | TW201006801A (enExample) |
| WO (1) | WO2010009062A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| ES2409215T3 (es) | 2007-09-14 | 2013-06-25 | Janssen Pharmaceuticals, Inc. | 4-fenil-1H-piridin-2-onas 1-3-disustituidas |
| PL2203439T3 (pl) | 2007-09-14 | 2011-06-30 | Addex Pharmaceuticals Sa | 1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony |
| JP5547194B2 (ja) | 2008-09-02 | 2014-07-09 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体 |
| BRPI0920354A2 (pt) | 2008-10-16 | 2017-06-27 | Addex Pharmaceuticals Sa | derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| AU2010246607B2 (en) | 2009-05-12 | 2012-09-27 | Addex Pharma S.A. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| KR101753826B1 (ko) | 2009-05-12 | 2017-07-04 | 얀센 파마슈티칼즈, 인코포레이티드 | 1,２,４―트리아졸로［４,３―ａ］피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도 |
| CA2815002C (en) | 2010-11-08 | 2019-10-22 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CN103261195B (zh) | 2010-11-08 | 2015-09-02 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| AU2011328194B2 (en) | 2010-11-08 | 2015-04-16 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| EP2966061B1 (en) | 2011-03-04 | 2017-05-03 | Life Technologies Corporation | Compounds and methods for conjugation of biomolecules |
| ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
| UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
| CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| SI3431106T1 (sl) | 2014-01-21 | 2021-03-31 | Janssen Pharmaceutica Nv | Kombinacije, ki vsebujejo pozitivne alosterične modulatorje metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba |
| LT3431106T (lt) | 2014-01-21 | 2021-02-10 | Janssen Pharmaceutica Nv | Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas |
| MX368391B (es) | 2015-02-03 | 2019-09-30 | Pfizer | Ciclopropabenzofuranil-piridopirazindionas novedosas. |
| JP6518789B2 (ja) * | 2015-04-23 | 2019-05-22 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 精神障害の処置において使用するためのテトラゾール誘導体 |
| CN104788694B (zh) * | 2015-04-29 | 2018-06-08 | 江苏亚宝绝缘材料股份有限公司 | 一种超低收缩率的聚酰亚胺薄膜 |
| JP6831376B2 (ja) | 2015-10-06 | 2021-02-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | トリアゾール誘導体 |
| CN108473462B (zh) | 2016-02-02 | 2021-06-22 | 豪夫迈·罗氏有限公司 | 作为eaat3抑制剂的吡唑-吡啶衍生物 |
| EP3464246B1 (en) | 2016-05-27 | 2020-07-08 | H. Hoffnabb-La Roche Ag | Pyrazol compounds as eaat3 inhibitors |
| CN109563049B (zh) | 2016-10-14 | 2022-11-29 | 豪夫迈·罗氏有限公司 | 作为eaat3抑制剂的咪唑化合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI802783A7 (fi) | 1979-09-05 | 1981-01-01 | Glaxo Group Ltd | Fenolijohdoksia. |
| US4666928A (en) | 1984-08-30 | 1987-05-19 | Merck Frosst Canada, Ind. | Propylphenoxy pyridine carboxylates as leukotriene antagonists |
| EP0516069B1 (en) | 1991-05-31 | 1996-04-24 | Sumitomo Pharmaceuticals Company, Limited | Leukotriene B4 antagonist |
| AU2001234420A1 (en) | 2000-02-03 | 2001-08-14 | Eli Lilly And Company | Potentiators of glutamate receptors |
| AU2003262805A1 (en) | 2002-08-26 | 2004-03-11 | Merck & Co., Inc. | Acetophenone potentiators of metabotropic glutamate receptors |
| EP1773792A1 (en) | 2004-07-30 | 2007-04-18 | Merck & Co., Inc. | Indanone potentiators of metabotropic glutamate receptors |
| JP2008508288A (ja) * | 2004-07-30 | 2008-03-21 | メルク エンド カムパニー インコーポレーテッド | 代謝調節型グルタミン酸受容体のヘテロ環式アセトフェノン増強剤 |
| TW200613272A (en) | 2004-08-13 | 2006-05-01 | Astrazeneca Ab | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| US20080096935A1 (en) | 2004-10-25 | 2008-04-24 | Pinkerton Anthony B | Heterocyclic Indanone Potentiators of Metabotropic Glutamate Receptors |
| DE602005020056D1 (de) * | 2004-11-22 | 2010-04-29 | Lilly Co Eli | Verstärker von glutamat-rezeptoren |
| WO2006071730A1 (en) | 2004-12-27 | 2006-07-06 | Astrazeneca Ab | Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| EP1912940A1 (en) | 2005-08-12 | 2008-04-23 | AstraZeneca AB | Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
-
2009
- 2009-07-10 TW TW098123468A patent/TW201006801A/zh unknown
- 2009-07-13 AR ARP090102635A patent/AR074631A1/es not_active Application Discontinuation
- 2009-07-14 CN CN2009801274345A patent/CN102099344B/zh not_active Expired - Fee Related
- 2009-07-14 JP JP2011518823A patent/JP5379227B2/ja not_active Expired - Fee Related
- 2009-07-14 HR HRP20120830AT patent/HRP20120830T1/hr unknown
- 2009-07-14 WO PCT/US2009/050440 patent/WO2010009062A1/en not_active Ceased
- 2009-07-14 SI SI200930350T patent/SI2318375T1/sl unknown
- 2009-07-14 KR KR1020117001166A patent/KR101287713B1/ko not_active Expired - Fee Related
- 2009-07-14 PT PT09790351T patent/PT2318375E/pt unknown
- 2009-07-14 PL PL09790351T patent/PL2318375T3/pl unknown
- 2009-07-14 DK DK09790351.2T patent/DK2318375T3/da active
- 2009-07-14 ES ES09790351T patent/ES2393243T3/es active Active
- 2009-07-14 US US12/502,252 patent/US7754742B2/en not_active Expired - Fee Related
- 2009-07-14 BR BRPI0915977A patent/BRPI0915977A2/pt not_active IP Right Cessation
- 2009-07-14 CA CA2731215A patent/CA2731215C/en not_active Expired - Fee Related
- 2009-07-14 EP EP09790351A patent/EP2318375B1/en active Active
- 2009-07-14 MX MX2011000611A patent/MX2011000611A/es active IP Right Grant
- 2009-07-14 EA EA201170227A patent/EA018434B1/ru not_active IP Right Cessation
-
2012
- 2012-11-07 CY CY20121101058T patent/CY1113315T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7754742B2 (en) | 2010-07-13 |
| EP2318375B1 (en) | 2012-09-19 |
| SI2318375T1 (sl) | 2012-11-30 |
| AR074631A1 (es) | 2011-02-02 |
| BRPI0915977A2 (pt) | 2018-10-30 |
| EP2318375A1 (en) | 2011-05-11 |
| AU2009271105A1 (en) | 2010-01-21 |
| CN102099344A (zh) | 2011-06-15 |
| KR20110022676A (ko) | 2011-03-07 |
| PL2318375T3 (pl) | 2013-02-28 |
| HRP20120830T1 (hr) | 2012-11-30 |
| JP2011528658A (ja) | 2011-11-24 |
| DK2318375T3 (da) | 2012-10-08 |
| JP5379227B2 (ja) | 2013-12-25 |
| US20100016373A1 (en) | 2010-01-21 |
| CA2731215A1 (en) | 2010-01-21 |
| WO2010009062A1 (en) | 2010-01-21 |
| KR101287713B1 (ko) | 2013-07-23 |
| ES2393243T3 (es) | 2012-12-19 |
| CN102099344B (zh) | 2013-10-30 |
| EA018434B1 (ru) | 2013-07-30 |
| EA201170227A1 (ru) | 2011-06-30 |
| MX2011000611A (es) | 2011-03-01 |
| CA2731215C (en) | 2013-08-27 |
| TW201006801A (en) | 2010-02-16 |
| CY1113315T1 (el) | 2016-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2318375E (pt) | Imidazole carboxamidas | |
| ES2319107T3 (es) | Derivados de 5-halo-triptamina usados como ligandos de los receptores de serotonina 5-ht6 y/o 5-ht7. | |
| TWI837169B (zh) | 甲狀腺素受體β促效劑化合物 | |
| TWI286474B (en) | Novel esters that are derived from indolealkanols and novel amides that are derived from indolealkylamines and the esters and the amides are selective COX-2 inhibitors | |
| PT701819E (pt) | Novas composicoes contendo sertralina e um agonista ou antagonista de receptor de 5-ht1d | |
| CA2642610A1 (en) | Amide derivative or salt thereof | |
| CN101679397A (zh) | 具有nos抑制活性的喹诺酮、四氢喹啉及其相关化合物 | |
| JPH05155858A (ja) | トロンボキサン受容体アンタゴニストである新規ベンズイミダゾールおよびアザベンズイミダゾール誘導体、それらの製造方法、およびそれらを含む合成中間体および薬剤組成物 | |
| BR112013000783A2 (pt) | derivados arilamídicos tendo propriedades antiandrogênicas | |
| ES2434250T3 (es) | Compuestos de 3-(fenoxifenilmetil)pirrolidina | |
| BRPI0921596B1 (pt) | Compostos de 4-[2-(2-fluorfenoximetil)fenil]piperidina, composição, método de preparação e uso relacionados | |
| KR900004385B1 (ko) | 카복사미드 유도체 및 그의 제조방법 | |
| NL1029919C2 (nl) | Therapeutische difenyletherliganden. | |
| US11236053B2 (en) | NADPH oxidase inhibitors and uses thereof | |
| JPH11513376A (ja) | 選択的β▲下３▼−アドレナリン作動剤 | |
| CN108084153A (zh) | 吡啶基硫代乙酸化合物、组合物及其应用 | |
| JPH02178263A (ja) | アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤 | |
| JPH06508378A (ja) | 新規アミドアルキル−およびイミドアルキル−ピペラジン類 | |
| BR112012022915B1 (pt) | composto de benzazepina e uso do mesmo para prevenção ou tratamento de doenças relacionadas ao receptor 5-ht2c | |
| BR112020004419A2 (pt) | formas sólidas de 2-(5-(4-(2-morfolinoetóxi)fenil)piridin-2-il)-n-benzilacetamida | |
| CN110003309B (zh) | 调节nmda受体活性的化合物、其药物组合物及用途 | |
| AU2009271105B2 (en) | Imidazole carboxamides | |
| US5179112A (en) | Heterocyclic amide derivatives and pharmaceutical use | |
| TW201623244A (zh) | 包含硫基團之４，５－二氫－１ｈ－吡唑－３－甲脒衍生物、其製備方法以及包含其之藥學組成物 | |
| HUP0501212A2 (en) | Optical isomers of dihydro-2,3-benzodiazepin, their stereoselective synthesis, pharmaceutical compositions containing them and their use |